Scleroderma Phase III SPHINX Study: uses & side-effects

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Filter by patients with:

Start typing to see suggestions

What is Scleroderma Phase III SPHINX Study?

Category: Others

The scleroderma phase III SPHINX study is a trial looking at apixaban in patients with pulmonary arterial hypertension associated with scleroderma or systemic sclerosis.

See patients taking Scleroderma Phase III SPHINX Study

See 1 patient that have used Scleroderma Phase III SPHINX Study

Last updated: April 26, 2026

There are no evaluations for Scleroderma Phase III SPHINX Study.

▲ Back to top